Skip to main content
. 2022 May 4;2022:6567916. doi: 10.1155/2022/6567916

Figure 7.

Figure 7

Drug sensitivity analysis. (a–i) Drugs for two groups. (a) Docetaxel. (b) Erlotinib. (c) AG.014699. (d) AKT.inhibitor.VIII. (e) Embelin. (f) ABT.888. (g) AS601245. (h) ATRA. (i) Axitinib. (j) Multiple drugs for eight signature genes.